CleanSpace Holdings Limited (CSX.AX)
AUD 0.39
(0.0%)
AUD 0.39
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 11.35 Million AUD | 320.23% |
| 2023 | -5.15 Million AUD | -152.89% |
| 2022 | 9.75 Million AUD | -75.78% |
| 2021 | 40.27 Million AUD | 215.45% |
| 2020 | 12.76 Million AUD | 277.09% |
| 2019 | 3.38 Million AUD | 55.71% |
| 2018 | 2.17 Million AUD | -17.54% |
| 2017 | 2.63 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 3.08 Million AUD | 0.0% |
| 2024 Q1 | 2.59 Million AUD | 256.86% |
| 2024 FY | 1.06 Million AUD | 120.72% |
| 2024 Q2 | -27.16 Thousand AUD | -101.05% |
| 2024 Q3 | 3.08 Million AUD | 11448.37% |
| 2023 Q4 | -1.65 Million AUD | -174.88% |
| 2023 FY | -5.15 Million AUD | -152.89% |
| 2023 Q3 | 2.21 Million AUD | 163.09% |
| 2023 Q2 | -3.5 Million AUD | -275.98% |
| 2023 Q1 | 1.99 Million AUD | 155.81% |
| 2022 Q4 | -3.56 Million AUD | -260.55% |
| 2022 Q1 | 2.65 Million AUD | 22.42% |
| 2022 FY | 9.75 Million AUD | -75.78% |
| 2022 Q3 | 2.22 Million AUD | 233.84% |
| 2022 Q2 | -1.66 Million AUD | -162.58% |
| 2021 Q1 | 15.53 Million AUD | 40.51% |
| 2021 Q4 | 2.16 Million AUD | -40.77% |
| 2021 Q3 | 3.65 Million AUD | -85.09% |
| 2021 Q2 | 24.53 Million AUD | 57.96% |
| 2021 FY | 40.27 Million AUD | 215.45% |
| 2020 Q4 | 11.05 Million AUD | 37.23% |
| 2020 Q2 | 1.7 Million AUD | -30.67% |
| 2020 FY | 12.76 Million AUD | 277.09% |
| 2020 Q1 | 2.46 Million AUD | 0.0% |
| 2020 Q3 | 8.05 Million AUD | 372.24% |
| 2019 FY | 3.38 Million AUD | 55.71% |
| 2018 FY | 2.17 Million AUD | -17.54% |
| 2017 FY | 2.63 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | -222.934% |
| Adherium Limited | -640.83 Thousand AUD | 1872.581% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 78.96% |
| Atomo Diagnostics Limited | 1.43 Million AUD | -690.651% |
| Anteris Technologies Ltd | 2.51 Million AUD | -351.271% |
| Control Bionics Limited | 3.67 Million AUD | -209.284% |
| CardieX Limited | 10.1 Million AUD | -12.382% |
| Compumedics Limited | 26.06 Million AUD | 56.424% |
| Cochlear Limited | 1.69 Billion AUD | 99.33% |
| Cyclopharm Limited | 4.49 Million AUD | -152.579% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -1.249% |
| Nova Eye Medical Limited | 20.19 Million AUD | 43.746% |
| HeraMED Limited | -504.09 Thousand AUD | 2353.408% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 669.992% |
| ImpediMed Limited | 9 Million AUD | -26.145% |
| InhaleRx Limited | 1.2 Million AUD | -843.429% |
| LBT Innovations Limited | -2.91 Million AUD | 489.418% |
| Micro-X Limited | 5.73 Million AUD | -98.001% |
| Neurotech International Limited | -5867.00 AUD | 193713.755% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -20318.678% |
| PolyNovo Limited | 36.08 Million AUD | 68.521% |
| Respiri Limited | 456.91 Thousand AUD | -2386.096% |
| SomnoMed Limited | 55.13 Million AUD | 79.396% |
| Universal Biosensors, Inc. | 4.28 Million AUD | -165.099% |
| Uscom Limited | 3.11 Million AUD | -264.584% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 4289.837% |